
ACXP Valuation
Acurx Pharmaceuticals Inc
- Overview
- Forecast
- Valuation
- Earnings
ACXP Relative Valuation
ACXP's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ACXP is overvalued; if below, it's undervalued.
Historical Valuation
Acurx Pharmaceuticals Inc (ACXP) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -2.50. The fair price of Acurx Pharmaceuticals Inc (ACXP) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:0.44
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
4.33
P/B
Median3y
6.96
Median5y
6.10
-66.40
FCF Yield
Median3y
-40.64
Median5y
-32.98
Competitors Valuation Multiple
The average P/S ratio for ACXP's competitors is 0.64, providing a benchmark for relative valuation. Acurx Pharmaceuticals Inc Corp (ACXP) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
People Also Watch

EQS
EQUUS Total Return Inc
1.440
USD
0.00%

NNVC
NanoViricides Inc
1.710
USD
-2.29%

BTAI
BioXcel Therapeutics Inc
1.730
USD
-4.42%

EDTK
Skillful Craftsman Education Technology Ltd
1.060
USD
0.00%

SYBX
Synlogic Inc
1.670
USD
+4.38%

ABVE
Above Food Ingredients Inc
1.740
USD
-14.71%

LIQT
LiqTech International Inc
2.450
USD
+2.94%

MLGO
MicroAlgo Inc
13.680
USD
-5.20%

LYT
Lytus Technologies Holdings Ptv Ltd
0.070
USD
-20.37%

JDZG
JIADE Ltd
2.540
USD
-13.90%
FAQ

Is Acurx Pharmaceuticals Inc (ACXP) currently overvalued or undervalued?
Acurx Pharmaceuticals Inc (ACXP) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -2.50. The fair price of Acurx Pharmaceuticals Inc (ACXP) is between to according to relative valuation methord.

What is Acurx Pharmaceuticals Inc (ACXP) fair value?

How does ACXP's valuation metrics compare to the industry average?

What is the current P/B ratio for Acurx Pharmaceuticals Inc (ACXP) as of Jul 25 2025?

What is the current FCF Yield for Acurx Pharmaceuticals Inc (ACXP) as of Jul 25 2025?

What is the current Forward P/E ratio for Acurx Pharmaceuticals Inc (ACXP) as of Jul 25 2025?
